Generic placeholder image

Recent Advances in Drug Delivery and Formulation

Editor-in-Chief

ISSN (Print): 2667-3878
ISSN (Online): 2667-3886

Mini-Review Article

Isoquinoline Quaternary Alkaloid (IQA) Nano-dressings: A Comprehensive Review on Design Strategies, Therapeutic Applications, and Advancements in Transdermal Delivery for Chronic Wound Management

Author(s): Iram Jahan, Jiyaul Hak, Suraj Mandal*, Shadab Ali, Sayad Ahad Ali and Nasiruddin Ahmad Farooqui

Volume 19, Issue 4, 2025

Published on: 11 April, 2025

Page: [305 - 326] Pages: 22

DOI: 10.2174/0126673878330005250326060103

Price: $65

Abstract

Introduction: Transdermal delivery systems and wound dressings are essential components of modern healthcare, with ongoing efforts focused on enhancing their efficacy, biocompatibility, and cost-effectiveness. Among emerging innovations, natural compounds, particularly those derived from plants, have shown great promise. Isoquinoline Quaternary Alkaloids (IQAs) are one such class of compounds with notable therapeutic properties, warranting exploration for advanced wound care applications.

Methods: This review investigates the design, fabrication techniques, and therapeutic potential of IQA-based nano dressings. It also provides a comparative analysis of these novel systems against conventional wound care methods to assess their advantages and clinical relevance.

Results: Dissolving IQA nano dressings exhibit transformative potential in chronic wound management. Their intrinsic properties, such as antimicrobial and anti-inflammatory activity, biocompatibility, and sustained drug release, support enhanced wound healing and reduced treatment burden.

Discussion: Compared to traditional approaches, IQA nano dressings offer improved outcomes and patient compliance, positioning them as a potential paradigm shift in wound care. By integrating nanotechnology with the unique pharmacological attributes of IQAs, these nano dressings demonstrate significant promise in promoting tissue regeneration while minimizing dressing frequency. This innovation holds the potential to revolutionize chronic wound treatment through safer, more effective, and patient-friendly therapeutic strategies.

Keywords: Wound care, nano dressing, isoquinoline quaternary alkaloid, chronic wounds, nanotechnology, antibiotic resistance.

Next »
Graphical Abstract
[1]
Mulder G, Jones R, Cederholm‐Williams S, Cherry G, Ryan T. Fibrin cuff lysis in chronic venous ulcers treated with a hydrocolloid dressing. Int J Dermatol 1993; 32(4): 304-6.
[http://dx.doi.org/10.1111/j.1365-4362.1993.tb04275.x] [PMID: 8486467]
[2]
Han G, Ceilley R. Chronic wound healing: A review of current management and treatments. Adv Ther 2017; 34(3): 599-610.
[http://dx.doi.org/10.1007/s12325-017-0478-y] [PMID: 28108895]
[3]
Snyder RJ, Kirsner RS, Warriner RA, Lavery LA, Hanft JR, Sheehan P. Consensus recommendations on advancing the standard of care for treating neuropathic foot ucers in patients with diabetes. Osto Wound Manag 2010; 56 (4 Suppl): S1-S24.
[PMID: 20424290]
[4]
Vijayakumar V, Samal SK, Mohanty S, Nayak SK. Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management. Int J Biol Macromol 2019; 122: 137-48.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.10.120] [PMID: 30342131]
[5]
Moholkar DN, Sadalage PS, Peixoto D, Paiva-Santos AC, Pawar KD. Recent advances in biopolymer-based formulations for wound healing applications. Eur Polym J 2021; 160: 110784.
[http://dx.doi.org/10.1016/j.eurpolymj.2021.110784]
[6]
Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. Wound healing dressings and drug delivery systems: A review. J Pharm Sci 2008; 97(8): 2892-923.
[http://dx.doi.org/10.1002/jps.21210] [PMID: 17963217]
[7]
Dhivya S, Padma VV, Santhini E. Wound dressings - A review. Biomedicine 2015; 5(4): 22.
[http://dx.doi.org/10.7603/s40681-015-0022-9] [PMID: 26615539]
[8]
Degreef HJ. How to heal a wound fast. Dermatol Clin 1998; 16(2): 365-75.
[http://dx.doi.org/10.1016/S0733-8635(05)70019-X] [PMID: 9589210]
[9]
Sarker SD, Nahar L. Chapter 4 - Organic, and Natural Product Chemistry. Chemistry for Pharmacy Students: General Hoboken, New Jersey. John Wiley & Sons, Ltd. 2013; pp. 1-29.
[http://dx.doi.org/10.1002/9781118687529]
[10]
Wang X, Feng S, Ding N, He Y, Li C, Li M, et al. Anti-inflammatory effects of berberine hydrochloride in an lps-induced murine model of mastitis. Evid Bas Compl Alternat Med 2018; 2018: 5164314.
[http://dx.doi.org/10.1155/2018/5164314] [PMID: 29849710]
[11]
Čerňáková M, Košťálová D. Antimicrobial activity of berberine—a constituent ofMahonia aquifolium. Folia Microbiol (Praha) 2002; 47(4): 375-8.
[http://dx.doi.org/10.1007/BF02818693] [PMID: 12422513]
[12]
Hostalkova A, Marikova J, Opletal L, et al. Isoquinoline alkaloids from Berberis vulgaris as potential lead compounds for the treatment of alzheimer’s disease. J Nat Prod 2019; 82(2): 239-48.
[http://dx.doi.org/10.1021/acs.jnatprod.8b00592] [PMID: 30701972]
[13]
Jian-Ling J, Guo-Qiang H, Zhen M, Gao P-J. Antibacterial mechanisms of berberine and reasons for little resistance of bacteria. Chin Herb Med 2010; 4: 27-35.
[14]
Qiu S, Sun H, Zhang AH, et al. Natural alkaloids: Basic aspects, biological roles, and future perspectives. Chin J Nat Med 2014; 12(6): 401-6.
[http://dx.doi.org/10.1016/S1875-5364(14)60063-7] [PMID: 24969519]
[15]
Bai R, Yao C, Zhong Z, et al. Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation. Eur J Med Chem 2021; 213: 113165.
[http://dx.doi.org/10.1016/j.ejmech.2021.113165] [PMID: 33454546]
[16]
Elsaid MB, Elnaggar DM, Owis AI, AbouZid SF, Eldahmy S. Production of isoquinoline alkaloids from the in vitro conserved Fumaria parviflora and their in vitro wound healing activity. Nat Prod Res 2022; 36(10): 2575-9.
[http://dx.doi.org/10.1080/14786419.2021.1904401] [PMID: 33823691]
[17]
Mensah AY, Houghton PJ, Dickson RA, Fleischer TC, Heinrich M, Bremner P. In vitro evaluation of effects of two ghanaian plants relevant to wound healing. Phyther Res 2006; 20(11): 941-4.
[http://dx.doi.org/10.1002/ptr.1978]
[18]
Tocco I, Zavan B, Bassetto F, Vindigni V. Nanotechnology-based therapies for skin wound regeneration. J Nanomater 2012; 2012(1): 714134.
[http://dx.doi.org/10.1155/2012/714134]
[19]
Mayet N, Choonara YE, Kumar P, et al. A comprehensive review of advanced biopolymeric wound healing systems. J Pharm Sci 2014; 103(8): 2211-30.
[http://dx.doi.org/10.1002/jps.24068] [PMID: 24985412]
[20]
Thomas V, Yallapu MM, Sreedhar B, Bajpai SK. Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application. J Biomater Sci Polym Ed 2009; 20(14): 2129-44.
[http://dx.doi.org/10.1163/156856209X410102] [PMID: 19874682]
[21]
Bird D, Ravindra NM. Transdermal drug delivery and patches: An overview. Med Devi Sens 2020; 3(6): e10069.
[http://dx.doi.org/10.1002/mds3.10069]
[22]
Hosseinpor H, Khaledi A, Esmaeili D. The properties of nanofiber scaffolds of polyurethane-Cinnamomum zeylanicum against pathogens of Pseudomonas aeruginosa and Staphylococcus aureus. Polym Bull 2021; 78(1): 223-45.
[http://dx.doi.org/10.1007/s00289-019-03095-1]
[23]
Archana D, Dutta J, Dutta PK. Evaluation of chitosan nano dressing for wound healing: Characterization, in vitro and in vivo studies. Int J Biol Macromol 2013; 57: 193-203.
[http://dx.doi.org/10.1016/j.ijbiomac.2013.03.002] [PMID: 23518244]
[24]
Ahani E, Montazer M, Toliyat T, Mahmoudi Rad M, Harifi T. Preparation of nano cationic liposome as carrier membrane for polyhexamethylene biguanide chloride through various methods utilizing higher antibacterial activities with low cell toxicity. J Microencapsul 2017; 34(2): 121-31.
[http://dx.doi.org/10.1080/02652048.2017.1296500] [PMID: 28609225]
[25]
Li T, Sun M, Wu S. State-of-the-art review of electrospun gelatin-based nanofiber dressings for wound healing applications. Nanomaterials (Basel) 2022; 12(5): 784.
[http://dx.doi.org/10.3390/nano12050784] [PMID: 35269272]
[26]
Zhao X, Wu H, Guo B, Dong R, Qiu Y, Ma PX. Antibacterial anti-oxidant electroactive injectable hydrogel as self-healing wound dressing with hemostasis and adhesiveness for cutaneous wound healing. Biomaterials 2017; 122: 34-47.
[http://dx.doi.org/10.1016/j.biomaterials.2017.01.011] [PMID: 28107663]
[27]
Kamoun EA, Kenawy ERS, Chen X. A review on polymeric hydrogel membranes for wound dressing applications: PVA-based hydrogel dressings. J Adv Res 2017; 8(3): 217-33.
[http://dx.doi.org/10.1016/j.jare.2017.01.005] [PMID: 28239493]
[28]
Plazas E, Avila MMC, Muñoz DR, Cuca SLE. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases. Pharmacol Res 2022; 177: 106126.
[http://dx.doi.org/10.1016/j.phrs.2022.106126] [PMID: 35151857]
[29]
Li N, Tan S, Cui J, et al. PA-1, a novel synthesized pyrrolizidine alkaloid, inhibits the growth of Escherichia coli and Staphylococcus aureus by damaging the cell membrane. J Antibiot (Tokyo) 2014; 67(10): 689-96.
[http://dx.doi.org/10.1038/ja.2014.49] [PMID: 24894184]
[30]
Liu D, Meng X, Wu D, Qiu Z, Luo H. A natural isoquinoline alkaloid with antitumor activity: Studies of the biological activities of berberine. Front Pharmacol 2019; 10: 9.
[http://dx.doi.org/10.3389/fphar.2019.00009] [PMID: 30837865]
[31]
Warren D. Wound healing and skin integrity wound healing and skin integrity. Int J Health Sci 2013; 6(S4): 5521-32.
[http://dx.doi.org/10.7748/phc2013.09.23.7.13.s13]
[32]
Herman A, Herman AP. Herbal products and their active constituents for diabetic wound healing—Preclinical and clinical studies. A systematic review Pharmaceutics 2023; 15(1): 281.
[http://dx.doi.org/10.3390/pharmaceutics15010281] [PMID: 36678910]
[33]
Haque ST, Saha SK, Haque ME, Biswas N. Nanotechnology-based therapeutic applications: In vitro and in vivo clinical studies for diabetic wound healing. Biomater Sci 2021; 9(23): 7705-47.
[http://dx.doi.org/10.1039/D1BM01211H] [PMID: 34709244]
[34]
Liu E, Gao H, Zhao Y, et al. The potential application of natural products in cutaneous wound healing: A review of preclinical evidence. Front Pharmacol 2022; 13: 900439.
[http://dx.doi.org/10.3389/fphar.2022.900439] [PMID: 35935866]
[35]
Wang W, Lu K, Yu C, Huang Q, Du YZ. Nano-drug delivery systems in wound treatment and skin regeneration. J Nanobiotechnology 2019; 17(1): 82.
[http://dx.doi.org/10.1186/s12951-019-0514-y] [PMID: 31291960]
[36]
Abazari M, Ghaffari A, Rashidzadeh H. Momeni badeleh S, Maleki Y. Current status and future outlook of nano‐based systems for burn wound management. J Biomed Mater Res B Appl Biomater 2020; 108(5): 1934-52.
[http://dx.doi.org/10.1002/jbm.b.34535] [PMID: 31886606]
[37]
Yandell P, Korzendorfer H, Hettrick H, Vaughn M, Gokoo C. The use of collagen dressings in long-term care: A retrospective case series. Wounds 2011; 23(8): 243-51.
[PMID: 25879235]
[38]
Rezvani Ghomi E, Khalili S, Nouri Khorasani S, Esmaeely Neisiany R, Ramakrishna S. Wound dressings: Current advances and future directions. J Appl Polym Sci 2019; 136(27): 47738.
[http://dx.doi.org/10.1002/app.47738]
[39]
Kajzar F, Pearce EM, Turovskij NA, Mukbaniani OV. Interdisciplinary concepts and research.Key Engineering Materials 1st Ed New Jersey. Apple Academic Press 2014; 2: p. 430.
[40]
Li JY, Wang XB, Luo JG, Kong LY. Seasonal variation of alkaloid contents and anti-inflammatory activity of Rhizoma coptidis based on fingerprints combined with chemometrics methods. J Chromatogr Sci 2015; 53(7): 1131-9.
[http://dx.doi.org/10.1093/chromsci/bmu175] [PMID: 25540292]
[41]
Khalaf YH, Dawood Y, Khashan AA. Green biosynthesis of berberine-mediated silver nanorods: Their protective and antidiabetic effects in streptozotocin-induced diabetic rats. Res Chem 2023; 5: 100722.
[http://dx.doi.org/10.1016/j.rechem.2022.100722]
[42]
Pei H, Zeng J, He Z, et al. Palmatine ameliorates LPS‐induced HT‐22 cells and mouse models of depression by regulating apoptosis and oxidative stress. J Biochem Mol Toxicol 2023; 37(1): e23225.
[http://dx.doi.org/10.1002/jbt.23225] [PMID: 36169195]
[43]
Fu G, Chen Z, Qi Y, Li H. Response surface methodology optimization and antimicrobial activity of berberine modified trimethoprim carboxymethyl cellulose. Nord Pulp Paper Res J 2023; 2: 271-84.
[http://dx.doi.org/10.1515/npprj-2022-0057]
[44]
Zhang R, Tian S, Zhang T, et al. Antibacterial activity mechanism of coptisine against Pasteurella multocida. Front Cell Infect Microbiol 2023; 13: 1207855.
[http://dx.doi.org/10.3389/fcimb.2023.1207855] [PMID: 37502603]
[45]
Dhungel J, Marasini BP, Manandhar E, Rathnayaka RK, Samarakoon SR, Shyaula SL. Cytotoxic activity of alkaloids isolated from Stephania glandulifera miers. J Biologi Act Prod Nat 2023; 13(2): 118-28.
[http://dx.doi.org/10.1080/22311866.2023.2224283]
[46]
Liang J, Li X, Bi C, et al. Sanguinarine, similar to the MICs of spectinomycin, exhibits good anti-Neisseria gonorrhoeae activity in vitro. J Infect Chemother 2023; 29(9): 927-9.
[http://dx.doi.org/10.1016/j.jiac.2023.05.022] [PMID: 37295648]
[47]
Malla RR, Bhamidipati P, Adem M. Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer. Biochem Pharmacol 2023; 212: 115565.
[http://dx.doi.org/10.1016/j.bcp.2023.115565] [PMID: 37086811]
[48]
Gu Y, Dong J, Li J, et al. Antibacterial activity and mechanism of sanguinarine against Staphylococcus aureus by interfering with the permeability of the cell wall and membrane and inducing bacterial ROS production. Front Vet Sci 2023; 10: 1121082.
[http://dx.doi.org/10.3389/fvets.2023.1121082] [PMID: 37065245]
[49]
Sirin S, Dolanbay NS, Aslim B. Role of plant derived alkaloids as antioxidant agents for neurodegenerative diseases Heal. Sci Rev 2023; 6: 100071.
[http://dx.doi.org/10.1016/j.hsr.2022.100071]
[50]
Rahman AFMM, Alam MS, Kwon Y. Editorial: Small organic molecules with anticancer activity. Front Chem 2023; 11: 1254312.
[http://dx.doi.org/10.3389/fchem.2023.1254312] [PMID: 37681208]
[51]
Calvillo-Páez VI, Plascencia-Jatomea M, Ochoa-Terán A, et al. Tetrandrine derivatives as promising antibacterial agents. ACS Omega 2023; 8(31): 28156-64.
[http://dx.doi.org/10.1021/acsomega.3c01368] [PMID: 37576675]
[52]
Platella C, Ghirga F, Musumeci D, et al. Selective targeting of cancer-related g-quadruplex structures by the natural compound dicentrine. Int J Mol Sci 2023; 24(4): 4070.
[http://dx.doi.org/10.3390/ijms24044070] [PMID: 36835480]
[53]
Arcaro G, Koga AY, Carletto B, Budel GM, da Rocha Gaspar MD, Nadal JM, et al. Preclinical trial of Ocotea puberula (rich.) nees (‘Canela-Guaicá’) in wound healing: Validation of a traditional medicine practice used by indigenous groups in southern Brazil. Evid Bas Compl Alternat Med 2023; 2023: 3641383.
[http://dx.doi.org/10.1155/2023/3641383] [PMID: 36818225]
[54]
Chen S, Wei B, Fu Y. A study of the chemical composition and biological activity of Michelia macclurei dandy heartwood: New sources of natural antioxidants, enzyme inhibitors and bacterial inhibitors. Int J Mol Sci 2023; 24(9): 7972.
[http://dx.doi.org/10.3390/ijms24097972] [PMID: 37175683]
[55]
Bandala C, Cárdenas-Rodríguez N, Mendoza-Torreblanca JG, et al. Therapeutic potential of dopamine and related drugs as anti-inflammatories and antioxidants in neuronal and non-neuronal pathologies. Pharmaceutics 2023; 15(2): 693.
[http://dx.doi.org/10.3390/pharmaceutics15020693] [PMID: 36840015]
[56]
Zhang W, Gao Y, Yang N, et al. Sinomenine-loaded microcapsules fabricated by phase reversion emulsification-drying in liquid method: An evaluation of process parameters, characterization, and released properties. J Bioact Compat Polym 2018; 33(4): 382-96.
[http://dx.doi.org/10.1177/0883911517751159]
[57]
Zhai X, Wang K, Gao X, Yan B. Research progress on chemical constituents and pharmacological activities of Menispermi rhizoma. Molecules 2023; 28(6): 2701.
[http://dx.doi.org/10.3390/molecules28062701] [PMID: 36985672]
[58]
Song L, Zhao F, Liu Y, Guo X, Wu C, Liu J. Effects of 8-amino-isocorydine, a derivative of isocorydine, on gastric carcinoma cell proliferation and apoptosis. Curr Ther Res Clin Exp 2021; 94: 100624.
[http://dx.doi.org/10.1016/j.curtheres.2021.100624] [PMID: 34306264]
[59]
Guo B, Li X, Song S, et al. (−)-β-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity. Oncol Rep 2016; 35(4): 2246-56.
[http://dx.doi.org/10.3892/or.2016.4594] [PMID: 26821251]
[60]
Gao X, Sun B, Hou Y, et al. Anti-breast cancer sinomenine derivatives via mechanisms of apoptosis induction and metastasis reduction. J Enzyme Inhib Med Chem 2022; 37(1): 1870-83.
[http://dx.doi.org/10.1080/14756366.2022.2096020] [PMID: 35801430]
[61]
Zhao C, Zhang C, Cui D, et al. Design, synthesis, biological evaluation and silico prediction of novel sinomenine derivatives. Adv Biomed 2021; 3(6)
[http://dx.doi.org/10.54730/abm.2021.030606]
[62]
Hu Y, Li B, Wen L, He K. Study on the anti-endotoxin effect of sinomenine using an Agilent genome array. QJM 2018; 111(3): 171-8.
[http://dx.doi.org/10.1093/qjmed/hcx234] [PMID: 29240916]
[63]
Yuan H, Zhang J, Li F, Li W, Wang H. Retracted: Sinomenine exerts antitumour effect in gastric cancer cells via enhancement of miR‐204 expression. Basic Clin Pharmacol Toxicol 2019; 125(5): 450-9.
[http://dx.doi.org/10.1111/bcpt.13285] [PMID: 31243880]
[64]
Gao F, Dai Z, Zhang T, et al. Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory and analgesic agent. RSC Advances 2022; 12(46): 30001-7.
[http://dx.doi.org/10.1039/D2RA05558A] [PMID: 36321084]
[65]
Kong Y, Li L, Zhao LG, Yu P, Li DD. A patent review of berberine and its derivatives with various pharmacological activities (2016–2020). Expert Opin Ther Pat 2022; 32(2): 211-23.
[http://dx.doi.org/10.1080/13543776.2021.1974001] [PMID: 34455891]
[66]
Och A, Zalewski D, Komsta Ł, Kołodziej P, Kocki J, Bogucka-Kocka A. Cytotoxic and proapoptotic activity of sanguinarine, berberine, and extracts of Chelidonium majus L. and Berberis thunbergii DC. Toward hematopoietic cancer cell lines. Toxins (Basel) 2019; 11(9): 485.
[http://dx.doi.org/10.3390/toxins11090485] [PMID: 31443589]
[67]
Samadian H, Zamiri S, Ehterami A, et al. Electrospun cellulose acetate/gelatin nanofibrous wound dressing containing berberine for diabetic foot ulcer healing: In vitro and in vivo studies. Sci Rep 2020; 10(1): 8312.
[http://dx.doi.org/10.1038/s41598-020-65268-7] [PMID: 32433566]
[68]
Gong N, Wang L, An L, Xu Y. Exploring the active ingredients and potential mechanisms of action of Sinomenium acutum in the treatment of rheumatoid arthritis based on systems biology and network pharmacology. Front Mol Biosci 2023; 10: 1065171.
[http://dx.doi.org/10.3389/fmolb.2023.1065171] [PMID: 36923645]
[69]
Zhang J-J, Zhou R, Deng L-J, Cao G-Z, Zhang Y, Xu H, et al. Huangbai liniment and berberine promoted wound healing in high-fat diet/Streptozotocin-induced diabetic rats. Biomed Pharmacother 2022; 150: 112948.
[http://dx.doi.org/10.1016/j.biopha.2022.112948] [PMID: 35430394]
[70]
Hu H, Luo F, Zhang Q, et al. Berberine coated biocomposite hemostatic film based alginate as absorbable biomaterial for wound healing. Int J Biol Macromol 2022; 209(Pt B): 1731-44.
[http://dx.doi.org/10.1016/j.ijbiomac.2022.04.132] [PMID: 35487376]
[71]
Lin J, Li C, Zhao Y, Hu J, Zhang LM. Co-electrospun nanofibrous membranes of collagen and zein for wound healing. ACS Appl Mater Interfaces 2012; 4(2): 1050-7.
[http://dx.doi.org/10.1021/am201669z] [PMID: 22242622]
[72]
Hu H, Zhong D, Li W, et al. Microalgae-based bioactive hydrogel loaded with quorum sensing inhibitor promotes infected wound healing. Nano Today 2022; 42: 101368.
[http://dx.doi.org/10.1016/j.nantod.2021.101368]
[73]
Paudel KR, Mehta M, Yin GHS, et al. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Environ Sci Pollut Res Int 2022; 29(31): 46830-47.
[http://dx.doi.org/10.1007/s11356-022-19158-2] [PMID: 35171422]
[74]
Shrivastav A, Mishra AK, Gupta AK. Evaluation of wound healing potential of root bark extract of Berberis aristata and molecular docking analysis of Berberis phytoconstituents. Curr Drug Discov Technol 2023; 20(3): e210223213867.
[http://dx.doi.org/10.2174/1570163820666230221154851] [PMID: 36824006]
[75]
Zhou W-C, Tan P-F, Chen X-H, Cen Y, You C, Tan L, et al. Berberine-incorporated shape memory fiber applied as a novel surgical suture. Front Pharmacol 2019; 10: 1506.
[http://dx.doi.org/10.3389/fphar.2019.01506] [PMID: 31998123]
[76]
Xie YY, Zhang Y-W, Liu X-Z, et al. Aggregation-induced emission-active amino acid/berberine hydrogels with enhanced photodynamic antibacterial and anti-biofilm activity. Chem Eng J 2021; 413: 127542.
[http://dx.doi.org/10.1016/j.cej.2020.127542]
[77]
Hashemi M, Kalalinia F, Razi M, et al. Evaluation of the efficiency of chitosan hydrogel containing Berberis integerrima root extract on a full-thickness skin wound in a rat model. Macromol Res 2022; 30(8): 527-35.
[http://dx.doi.org/10.1007/s13233-022-0043-7]
[78]
Lu J, Wang Z, Cai D, et al. Carrier-free binary self-assembled nanomedicines originated from traditional herb medicine with multifunction to accelerate mrsa-infected wound healing by antibacterial, anti-inflammation and promoting angiogenesis. Int J Nanomedicine 2023; 18: 4885-906.
[http://dx.doi.org/10.2147/IJN.S422944] [PMID: 37667771]
[79]
Neag MA, Mocan A, Echeverría J, et al. Berberine: Botanical Occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol 2018; 9: 557.
[http://dx.doi.org/10.3389/fphar.2018.00557] [PMID: 30186157]
[80]
Zheng T, Chen H, Wu C, et al. Fabrication of co-assembly from berberine and tannic acid for multidrug-resistant bacteria infection treatment. Pharmaceutics 2023; 15(7): 1782.
[http://dx.doi.org/10.3390/pharmaceutics15071782] [PMID: 37513970]
[81]
Ma W, Zhu M, Zhang D, et al. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2. Phytomedicine 2017; 25: 45-51.
[http://dx.doi.org/10.1016/j.phymed.2016.12.013] [PMID: 28190470]
[82]
Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. L-tetrahydropalmatine ameliorates development of anxiety and depression-related symptoms induced by single prolonged stress in rats. Biomol Ther (Seoul) 2014; 22(3): 213-22.
[http://dx.doi.org/10.4062/biomolther.2014.032] [PMID: 25009702]
[83]
Guterres ZR, da Silva AFG, Garcez WS, Garcez FR, Fernandes CA, Garcez FR. Mutagenicity and recombinagenicity of Ocotea acutifolia (Lauraceae) aporphinoid alkaloids. Mutat Res Genet Toxicol Environ Mutagen 2013; 757(1): 91-6.
[http://dx.doi.org/10.1016/j.mrgentox.2013.07.004] [PMID: 23892138]
[84]
Bashir DJ, Manzoor S, Sarfaraj M, Afzal SM, Bashir M, Nidhi A, et al. Magnoflorine-loaded chitosan collagen nanocapsules ameliorate cognitive deficit in scopolamine-induced alzheimer’s disease-like conditions in a rat model by downregulating il-1β, il-6, tnf-α, and oxidative stress and upregulating brain-derived neurotrophi. ACS Omega 2022; 8(2): 2227-36.
[http://dx.doi.org/10.1021/acsomega.2c06467] [PMID: 36687096]
[85]
Szalak R, Matysek M, Koval M, et al. Magnoflorine from Berberis vulgaris roots—impact on hippocampal neurons in mice after short-term exposure. Int J Mol Sci 2023; 24(8): 7166.
[http://dx.doi.org/10.3390/ijms24087166] [PMID: 37108329]
[86]
Kim J, Ha Quang Bao T, Shin YK, Kim KY. Antifungal activity of magnoflorine against Candida strains. World J Microbiol Biotechnol 2018; 34(11): 167.
[http://dx.doi.org/10.1007/s11274-018-2549-x] [PMID: 30382403]
[87]
Luo N, Jin L, Yang C, et al. Antifungal activity and potential mechanism of magnoflorine against Trichophyton rubrum. J Antibiot (Tokyo) 2021; 74(3): 206-14.
[http://dx.doi.org/10.1038/s41429-020-00380-4] [PMID: 33082529]
[88]
Baran M, Miziak P, Bonio K. Magnoflorine – A compound with anti-tumour activity. J Pre-Clini Clini Res 2020; 14(3): 98-101.
[http://dx.doi.org/10.26444/jpccr/127326]
[89]
Patel MB, Mishra SM. Magnoflorine from Tinospora cordifolia stem inhibits α-glucosidase and is antiglycemic in rats. J Funct Foods 2012; 4(1): 79-86.
[http://dx.doi.org/10.1016/j.jff.2011.08.002]
[90]
Zhong L, Qin Y, Liu M, et al. Magnoflorine improves cognitive deficits and pathology of Alzheimer’s disease via inhibiting of JNK signaling pathway. Phytomedicine 2023; 112: 154714.
[http://dx.doi.org/10.1016/j.phymed.2023.154714] [PMID: 36812746]
[91]
Kukula-Koch W, Kruk-Słomka M, Stępnik K, Szalak R, Biała G. The evaluation of pro-cognitive and antiamnestic properties of berberine and magnoflorine isolated from barberry species by centrifugal partition chromatography (CPC), in relation to QSAR modelling. Int J Mol Sci 2017; 18(12): 2511.
[http://dx.doi.org/10.3390/ijms18122511] [PMID: 29186770]
[92]
Okon E, Kukula-Koch W, Halasa M, et al. Magnoflorine—isolation and the anticancer potential against nci-h1299 lung, mda-mb-468 breast, t98g glioma, and te671 rhabdomyosarcoma cancer cells. Biomolecules 2020; 10(11): 1532.
[http://dx.doi.org/10.3390/biom10111532] [PMID: 33182753]
[93]
Ueda M, Hirayama Y, Ogawa H, Nomura T, Terashi H, Sakakibara S. Vasodilating effects of antispasmodic agents and their cytotoxicity in vascular smooth muscle cells and endothelial cells—potential application in microsurgery. Int J Mol Sci 2023; 24(13): 10850.
[http://dx.doi.org/10.3390/ijms241310850] [PMID: 37446027]
[94]
Gaber A, Alsanie WF, Kumar DN, Refat MS, Saied EM. Novel papaverine metal complexes with potential anticancer activities. Molecules 2020; 25(22): 5447.
[http://dx.doi.org/10.3390/molecules25225447] [PMID: 33233775]
[95]
Heffez DS, Leong KW. Sustained release of papaverine for the treatment of cerebral vasospasm: In vitro evaluation of release kinetics and biological activity. J Neurosurg 1992; 77(5): 783-7.
[http://dx.doi.org/10.3171/jns.1992.77.5.0783] [PMID: 1403123]
[96]
Wang F, Zhang Y, Pang R, Shi S, Wang R. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis. Acta Pharm 2023; 73(3): 475-88.
[http://dx.doi.org/10.2478/acph-2023-0021] [PMID: 37708956]
[97]
Tian J, Mo J, Xu L, et al. Scoulerine promotes cell viability reduction and apoptosis by activating ROS-dependent endoplasmic reticulum stress in colorectal cancer cells. Chem Biol Interact 2020; 327: 109184.
[http://dx.doi.org/10.1016/j.cbi.2020.109184] [PMID: 32590070]
[98]
Wangchuk P, Keller PA, Pyne SG, Willis AC, Kamchonwongpaisan S. Antimalarial alkaloids from a Bhutanese traditional medicinal plant Corydalis dubia. J Ethnopharmacol 2012; 143(1): 310-3.
[http://dx.doi.org/10.1016/j.jep.2012.06.037] [PMID: 22796506]
[99]
Hitotsuyanagi Y, Nishimura K, Ikuta H, Takeya K, Itokawa H. ChemInform abstract: Syntheses of antitumor morphinane alkaloids, sinococuline (IX) and 6‐ epi‐ (XI), 7‐epi‐ (X), and 6‐epi‐7‐epi‐sinococuline (XII), from sinomenine (I). ChemInform 1995; 26(48): chin.199548230.
[http://dx.doi.org/10.1002/chin.199548230]
[100]
Kilic M, Sener B, Kaya E. Anti-cholinergic activities of Turkish Corydalis DC. species. Phytochem Lett 2021; 45: 142-56.
[http://dx.doi.org/10.1016/j.phytol.2021.08.006]
[101]
Wangchuk P, Sastraruji T, Taweechotipatr M, Keller PA, Pyne SG. Anti-inflammatory, anti-bacterial and anti-acetylcholinesterase activities of two isoquinoline alkaloids-scoulerine and cheilanthifoline. Nat Prod Commun 2016; 11(12): 1934578X1601101207.
[http://dx.doi.org/10.1177/1934578X1601101207] [PMID: 30508337]
[102]
Shukla R, Ahuja R, Beesetti H, et al. Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity. Sci Rep 2023; 13(1): 1026.
[http://dx.doi.org/10.1038/s41598-023-27927-3] [PMID: 36658277]
[103]
Ho J, Leung Y, Chan C. Herbal medicine in the treatment of cancer. Curr Med Chem Anticancer Agents 2002; 2(2): 209-14.
[http://dx.doi.org/10.2174/1568011023354164] [PMID: 12678744]
[104]
Warowicka A, Nawrot R, Goździcka-Józefiak A. Antiviral activity of berberine. Arch Virol 2020; 165(9): 1935-45.
[http://dx.doi.org/10.1007/s00705-020-04706-3] [PMID: 32594322]
[105]
Kocić BD, Dimitrijević MV, Miladinović LC, Marković MS, Ranković GŽ, Miladinović DL. In vitro anti-Helicobacter pylori activity of berberine and barberry extracts: A preliminary report. Nat Prod Commun 2019; 14(6): 1934578X19857905.
[http://dx.doi.org/10.1177/1934578X19857905]
[106]
Liu Y, Long S, Zhang S, et al. Synthesis and antioxidant activities of berberine 9- O -benzoic acid derivatives. RSC Advances 2021; 11(29): 17611-21.
[http://dx.doi.org/10.1039/D1RA01339D] [PMID: 35480221]
[107]
Nguyen HT, Pham TN, Le AT, Thuy NT, Huy TQ, Nguyen TTT. Antibacterial activity of a berberine nanoformulation. Beilstein J Nanotechnol 2022; 13: 641-52.
[http://dx.doi.org/10.3762/bjnano.13.56] [PMID: 35923171]
[108]
Luo A, Fan Y. Antioxidant activities of berberine hydrochloride. J Med Plants Res 2011; 5(16): 3702-7.
[109]
Xu J, Rong S, Qin Z, et al. Preparation of berberine@carbon dots nano-formulation: Synthesis, characterization and herbicidal activity against Echinochloa crus-galli and Amaranthus retroflexus two common species of weed. Nanomaterials (Basel) 2022; 12(24): 4482.
[http://dx.doi.org/10.3390/nano12244482] [PMID: 36558335]
[110]
Das K, Iyer KR, Orfali R, et al. In silico studies and evaluation of in vitro antidiabetic activity of berberine from ethanol seed extract of Coscinium fenestratum (Gaertn.) Colebr. J King Saud Univ Sci 2023; 35(5): 102666.
[http://dx.doi.org/10.1016/j.jksus.2023.102666]
[111]
Milata V, Svedova A, Barbierikova Z, et al. Synthesis and anticancer activity of novel 9-O-substituted berberine derivatives. Int J Mol Sci 2019; 20(9): 2169.
[http://dx.doi.org/10.3390/ijms20092169] [PMID: 31052469]
[112]
Milani G, Cavalluzzi MM, Solidoro R, et al. Molecular simplification of natural products: Synthesis, antibacterial activity, and molecular docking studies of berberine open models. Biomedicines 2021; 9(5): 452.
[http://dx.doi.org/10.3390/biomedicines9050452] [PMID: 33922200]
[113]
Utami AR, Maksum IP, Deawati Y. Berberine and its study as an antidiabetic compound. Biology (Basel) 2023; 12(7): 973.
[http://dx.doi.org/10.3390/biology12070973] [PMID: 37508403]
[114]
Kumari A, Singla R, Guliani A, Yadav SK. Nanoencapsulation for drug delivery. EXCLI J 2014; 13: 265-86.
[PMID: 26417260]
[115]
Gul A, Gallus I, Tegginamath A, Maryska J, Yalcinkaya F. Electrospun antibacterial nanomaterials for wound dressings applications. Membranes (Basel) 2021; 11(12): 908.
[http://dx.doi.org/10.3390/membranes11120908] [PMID: 34940410]
[116]
Hu W, Wang Z, Zha Y, et al. High flexible and broad antibacterial nanodressing induces complete skin repair with angiogenic and follicle regeneration. Adv Healthc Mater 2020; 9(23): 2000035.
[http://dx.doi.org/10.1002/adhm.202000035] [PMID: 32378346]
[117]
Omidian H, Chowdhury SD. Advancements and applications of injectable hydrogel composites in biomedical research and therapy. Gels 2023; 9(7): 533.
[http://dx.doi.org/10.3390/gels9070533] [PMID: 37504412]
[118]
Wang M, Wang C, Chen M, et al. Efficient angiogenesis-based diabetic wound healing/skin reconstruction through bioactive antibacterial adhesive ultraviolet shielding nanodressing with exosome release. ACS Nano 2019; 13(9): 10279-93.
[http://dx.doi.org/10.1021/acsnano.9b03656] [PMID: 31483606]
[119]
Bhatt T, Kumar H, Jain R, Jain V. Emerging applications of electrospun nanofibers using various fabrication techniques. Ind J Pharmaceut Educ Res 2023; 57(3): 1966-7.
[http://dx.doi.org/10.5530/ijper.57.3.80]
[120]
Nematpour N, Farhadian N, Ebrahimi KS, et al. Sustained release nanofibrous composite patch for transdermal antibiotic delivery. Colloids Surf A Physicochem Eng Asp 2020; 586: 124267.
[http://dx.doi.org/10.1016/j.colsurfa.2019.124267]
[121]
Zhang Y, Li K, Shen L, et al. Metal phenolic nanodressing of porous polymer scaffolds for enhanced bone regeneration via interfacial gating growth factor release and stem cell differentiation. ACS Appl Mater Interfaces 2022; 14(1): 268-77.
[http://dx.doi.org/10.1021/acsami.1c19633] [PMID: 34961319]
[122]
Hu X, Liu S, Zhou G, Huang Y, Xie Z, Jing X. Electrospinning of polymeric nanofibers for drug delivery applications. J Control Release 2014; 185: 12-21.
[http://dx.doi.org/10.1016/j.jconrel.2014.04.018] [PMID: 24768792]
[123]
Pillay V, Dott C, Choonara YE, et al. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J Nanomater 2013; 2013(1): 789289.
[http://dx.doi.org/10.1155/2013/789289]
[124]
Liu M, Duan XP, Li YM, Yang DP, Long YZ. Electrospun nanofibers for wound healing. Mater Sci Eng C 2017; 76: 1413-23.
[http://dx.doi.org/10.1016/j.msec.2017.03.034] [PMID: 28482508]
[125]
Elnaggar M, Shalaby E, Abd-Al-Aleem AAA, Youssef A. Nanomaterials and nanofibers as wound dressing mats: An overview of the fundamentals, properties and applications. Egypt J Chem 2021. 0(0): 0.
[http://dx.doi.org/10.21608/ejchem.2021.91351.4345]
[126]
Mascarenhas-Melo F, Gonçalves MBS, Peixoto D, et al. Application of nanotechnology in management and treatment of diabetic wounds. J Drug Target 2022; 30(10): 1-21.
[http://dx.doi.org/10.1080/1061186X.2022.2092624] [PMID: 35735061]
[127]
Augustine R. Electrospun polymer nanocomposite scaffolds containing metal oxide nanoparticles for diabetic wound healing Qat Founda Ann Res Confer Proc 2019; 2018(2): HBPD1163.
[http://dx.doi.org/10.5339/qfarc.2018.HBPD1163]
[128]
Rahmani H, Mahmoudi Najafi SH, Ashori A, Arab Fashapoyeh M, Aziz Mohseni F, Torkaman S. Preparation of chitosan-based composites with urethane cross linkage and evaluation of their properties for using as wound healing dressing. Carbohydr Polym 2020; 230: 115606.
[http://dx.doi.org/10.1016/j.carbpol.2019.115606] [PMID: 31887878]
[129]
Zhao Y, Wang Z, Lv Y, Li S, Ge W, He C, et al. Conformal fabrication of thick superhydrophobic coatings via reduction of sorption barrier against multiple damages. Surf Coat Technol 2022; 444: 128658.
[http://dx.doi.org/10.1016/j.surfcoat.2022.128658]
[130]
Augustine R, Rehman SRU, Ahmed R, et al. Electrospun chitosan membranes containing bioactive and therapeutic agents for enhanced wound healing. Int J Biol Macromol 2020; 156: 153-70.
[http://dx.doi.org/10.1016/j.ijbiomac.2020.03.207] [PMID: 32229203]
[131]
Miguel SP, Moreira AF, Correia IJ. Chitosan based-asymmetric membranes for wound healing: A review. Int J Biol Macromol 2019; 127: 460-75.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.01.072] [PMID: 30660567]

Rights & Permissions Print Cite
© 2026 Bentham Science Publishers | Privacy Policy